Natixis’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Natixis’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-67,851	Closed	-$2.67M	–	1174
2023 Q2	$2.67M	Buy	+67,851	New	+$2.39M	0.02%	384

Natixis's ISEE Position: Q3 2023 in Review

Natixis sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 67,851 shares — an estimated $2.67M sold.

Natixis first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $2.67M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Natixis reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Natixis sold 67,851 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.67M.
Natixis first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Natixis's IVERIC bio, Inc. Common Stock position peaked at $2.67M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.